Nanoparticle technology demonstrates selective destruction of leukemia cancer cells
Nanoparticle technology demonstrates selective destruction of leukemia cancer cells- A research team, affiliated with UNIST has developed nanoparticles that effectively treat acute myeloid leukemia (AML), offering the potential to reduce side effects while enhancing therapeutic efficacy by selectively targeting and eliminating leukemia cells.
Source: phys.org